Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cited by (1,048)

Items 601–700 of 1,048

1. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein
   Miloslav Šanda, Lindsay J. Morrison, Radoslav Goldman · 2021 · Analytical Chemistry
2. Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection
   Rohmad Yudi Utomo, Muthi Ikawati, Edy Meiyanto · 2020 · Preprints.org
3. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
   Isabelle Bernard, Daniel Limonta, Lara K. Mahal, Tom C. Hobman · 2020 · Viruses
4. Understanding the invisible hands of sample preparation for cryo-EM
   Giulia Weissenberger, René Henderikx, Peter J. Peters · 2021 · Nature Methods
5. Proteolytic activation of SARS‐CoV‐2 spike protein
   Makoto Takeda · 2021 · Microbiology and Immunology
6. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies
   Rahila Sardar, Deepshikha Satish, Shweta Birla, Dinesh Kumar Gupta · 2020 · Heliyon
7. A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
   Monir Ejemel, Qi Li, Shurong Hou, Zachary A. Schiller, Julia A. Tree, Aaron Wallace, Alla Amcheslavsky, Neşe Kurt Yılmaz, Karen R. Buttigieg, Michael J. Elmore et al. · 2020 · Nature Communications
8. Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection
   Li Guo, Zhiqian Yao, Lu Yang, Hao Zhang, Yu Qi, Lu Gou, Xi Wang, Dingxin Liu, Lei Zhang, Yilong Cheng et al. · 2020 · Chemical Engineering Journal
9. Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection
   Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre‐Bosquet, Marloes Grobben, Mathieu A. F. Claireaux, Marlon de Gast, Romain Marlin, Virginie Chesnais, Ségolène Diry et al. · 2020 · Cell
10. MOF‐Directed Synthesis of Crystalline Ionic Liquids with Enhanced Proton Conduction
    Wen‐Long Xue, Weihua Deng, Hui Chen, Rui‐Heng Liu, Jared M. Taylor, Yu‐kun Li, Lu Wang, Yu‐Heng Deng, Wenhua Li, Yingyi Wen et al. · 2020 · Angewandte Chemie International Edition
11. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
    Meng Yuan, Hejun Liu, Nicholas C. Wu, Ian A. Wilson · 2020 · Biochemical and Biophysical Research Communications
12. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor
    Anne M. Davidson, Jan A Wysocki, DANIEL C. BATLLE · 2020 · Hypertension
13. Peptide and peptide-based inhibitors of SARS-CoV-2 entry
    Desirée Schütz, Yasser B. Ruiz‐Blanco, Jan Münch, Frank Kirchhoff, Elsa Sánchez‐García, Janis A. Müller · 2020 · Advanced Drug Delivery Reviews
14. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection
    Cornelia Blume, Claire L. Jackson, Cosma Mirella Spalluto, Jelmer Legebeke, Liliya Nazlamova, Franco Conforti, Jeanne‐Marie Perotin, Martin Frank, John Butler, Max Crispin et al. · 2021 · Nature Genetics
15. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells
    Michihito Sasaki, Kentaro Uemura, Akihiko Sato, Shinsuke Toba, Takao Sanaki, Katsumi Maenaka, William W. Hall, Yasuko Orba, Hirofumi Sawa · 2021 · PLoS Pathogens
16. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
    Corey Allan Siegel, GIL Y. MELMED, Dermot P.B. McGovern, Victoria Rai, Florian Krammer, David T. Rubin, Maria Teresa Abreu, Marla Cindy Dubinsky · 2021 · Gut
17. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
    Michael Gordon Joyce, Wei‐Hung Chen, Rajeshwer Singh Sankhala, Agnes Hajduczki, Paul V. Thomas, Misook Choe, Elizabeth J. Martinez, William C. Chang, Caroline E. Peterson, Elaine B. Morrison et al. · 2021 · Cell Reports
18. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
    2022
19. The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
    Yuzhi Liu, Chengyuan Liang, Liang Xin, Xiaodong Ren, Lei Tian, Xingke Ju, Li Han, Yongbo Wang, Qianqian Zhao, Hong Liu et al. · 2020 · European Journal of Medicinal Chemistry
20. Comparative ACE2 variation and primate COVID-19 risk
    Amanda Dawn Melin, Mareike C. Janiak, Frank Marrone, Paramjit S. Arora, James P. Higham · 2020 · Communications Biology
21. Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
    Kemmian D. Johnson, C. C. Harris, John Cain, Cicily Hummer, Hemant Goyal, Abhilash Perisetti · 2020 · Frontiers in Medicine
22. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
    Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, Peter Andrew McCullough · 2022 · Food and Chemical Toxicology
23. Antivirals with common targets against highly pathogenic viruses
    Lu Lu, Shan Su, Haitao Yang, Shibo Jiang · 2021 · Cell
24. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies
    Xing Quan Zhu, Dhiraj Mannar, Shanti Swaroop Srivastava, Alison Berezuk, Jean‐Philippe Demers, James W. Saville, Karoline Leopold, Wei Li, Dimiter Stanchev Dimitrov, Katharine S. Tuttle et al. · 2021 · PLoS Biology
25. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
    Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, Olivier Schwartz · 2021 · Journal of Molecular Biology
26. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice
    Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, Emanuelle Vasconcellos de Lima, Leticia S. Antonio, Mariana Beiral Hämmerle, Hannah P. Mota-Araujo, Lilian C. Colodeti, Suzana Maria Bernardino Araújo, Gabrielle M. Froz et al. · 2023 · Cell Reports
27. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening
    Xiaoxuan Zhao, Yuepeng Jiang, Yang Zhao, Hongyan Xi, Chang Liu, Fan Qu, Xiaoling Feng · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
28. The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET
    Sunil Thomas · 2020 · Pathogens and Immunity
29. Impact of Thiol–Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor
    Sanchita Hati, Sudeep Bhattacharyya · 2020 · ACS Omega
30. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19
    Shigeru Shibata, Hisatomi Arima, Kei Asayama, Satoshi Hoshide, Atsuhiro Ichihara, Toshihiko Ishimitsu, Kazuomi Kario, Takuya Kishi, Masaki Mogi, Akira Nishiyama et al. · 2020 · Hypertension Research
31. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
    Ganna Petruk, Manoj Puthia, Jitka Petrlová, Firdaus Samsudin, Ann‐Charlotte Strömdahl, Samuel Cerps, Lena Uller, Sven Kjellström, Peter John Bond, Artur Schmidtchen · 2020 · Journal of Molecular Cell Biology
32. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
    Chunyan Wang, Rien van Haperen, J. Gutiérrez-Álvarez, Wen-Tao Li, Nisreen M. A. Okba, I. Albulescu, Ivy Widjaja, Brenda van Dieren, R. Fernández-Delgado, I. Sola et al. · 2021 · Nature Communications
33. Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant
    Gard Nelson, Oleksandr V. Buzko, Patricia Spilman, Kayvan Niazi, Shahrooz Rabizadeh, Patrick Soon‐Shiong · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
34. Prolonged evolution of the human B cell response to SARS-CoV-2 infection
    Sakharkar, Mrunal, Rappazzo, C. Garrett, Wieland-Alter, Wendy F., Hsieh, Ching-Lin, Wrapp, Daniel, Esterman, Emma S., Kaku, Chengzi I., Wec, Anna Z., Geoghegan, James C., McLellan, Jason S. et al. · 2021 · Science Immunology
35. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
    Jennifer A. Aguiar, Benjamin J.-M. Tremblay, Michael J. Mansfield, Owen Z. Woody, Briallen Lobb, Arinjay Banerjee, Abiram Chandiramohan, Nicholas Tiessen, Quynh Cao, Anna Dvorkin‐Gheva et al. · 2020 · European Respiratory Journal
36. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
    Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma, Ji Ma, Viktor Lemmens, Dominique Van Looveren, Mahadesh Prasad Arkalagud Javarappa, Robbert Boudewijns, Bert Malengier‐Devlies, Laurens Liesenborghs et al. · 2020 · Nature
37. A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV‑2 in Mice
    Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, Shaogeng Tang, Payton A. B. Weidenbacher, Shanshan Li, Tho D. Pham, John E. Pak, Wah Chiu, Peter S. Kim · 2021 · ACS Central Science
38. Structural basis for broad coronavirus neutralization
    Maximilian M. Sauer, M. Alejandra Tortorici, Young‐Jun Park, Alexandra C. Walls, Leah J. Homad, Oliver J. Acton, John E. Bowen, Chunyan Wang, Xiaoli Xiong, Willem de van der Schueren et al. · 2021 · Nature Structural & Molecular Biology
39. Molecularly imprinted polymer based electrochemical sensor for quantitative detection of SARS-CoV-2 spike protein
    Akinrinade George Ayankojo, Roman Boroznjak, Jekaterina Reut, Andres Öpik, Vitali Syritski · 2021 · Sensors and Actuators B Chemical
40. Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial
    Pollock, Katrina M., Cheeseman, Hannah M., Szubert, Alexander J., Libri, Vincenzo, Boffito, Marta, Owen, David, Bern, Henry, McFarlane, Leon R., O'Hara, Jessica, Lemm, Nana-Marie et al. · 2022 · eClinicalMedicine
41. SARS-CoV-2, ACE2 expression, and systemic organ invasion
    Usman Ashraf, Ahmed A. Abokor, Jonnelle M. Edwards, Emily W. Waigi, Rachel Royfman, Syed Abdul‐Moiz Hasan, Kathryn Smedlund, Ana Maria Trindade Grégio, Ritu Chakravarti, Lauren G. Koch · 2020 · Physiological Genomics
42. Neutralization, effector function and immune imprinting of Omicron variants
    Amin Addetia, Luca Piccoli, James Brett Case, Young‐Jun Park, Martina Beltramello, Barbara Guarino, Ha V. Dang, Guilherme Dias de Melo, Dora Pinto, Kaitlin R. Sprouse et al. · 2023 · Nature
43. A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world
    Nicola Bellomo, Richard J. Bingham, Mark A. J. Chaplain, Giovanni Dosi A, Guido Forni, Damian A. Knopoff, John S. Lowengrub, Reidun Twarock, Maria Enrica Virgillito · 2020 · Mathematical Models and Methods in Applied Sciences
44. Scoring Systems for Predicting Mortality for Severe Patients with COVID-19
    Yufeng Shang, Tao Liu, Yongchang Wei, Jingfeng Li, Liang Shao, Minghui Liu, Yongxi Zhang, Zhigang Zhao, Haibo Xu, Zhiyong Peng et al. · 2020 · EClinicalMedicine
45. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
    Ahmed Mostafa, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel Ahmed Rashad, Mahmoud Shehata, Mokhtar R. Gomaa, Noura Mahrous, Sara Hussein Mahmoud et al. · 2020 · Pharmaceuticals
46. SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
    Alona Kuzmina, Yara Khalaila, Olga Voloshin, Ayelet Keren‐Naus, Liora Boehm Cohen, Yael Raviv, Yonat Shemer‐Avni, Elli Rosenberg, Ran Taube · 2021 · Cell Host & Microbe
47. Systems serology detects functionally distinct coronavirus antibody features in children and elderly
    Kevin John Selva, Carolien E. van de Sandt, Melissa M. Lemke, Christina Y. Lee, Suzanne K. Shoffner, Brendon Yew Loong Chua, Samantha K. Davis, Thi H. O. Nguyen, Louise C. Rowntree, Luca Hensen et al. · 2021 · Nature Communications
48. Rapid Point-of-Care COVID-19 Diagnosis with a Gold-Nanoarchitecture-Assisted Laser-Scribed Graphene Biosensor
    Tutku Bedük, Duygu Beduk, José Ilton de Oliveira Filho, Figen Zihnioğlu, Candan Çiçek, Ruchan Yazan Sertoz, Bilgin Arda, Tuncay Göksel, Kutsal Turhan, Khaled Nabil Salama et al. · 2021 · Analytical Chemistry
49. Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
    Juan F. Burgueño, Adrian M. Reich, Hajar Hazime, Maria A. Quintero, Irina Fernández, Júlia Fritsch, Ana M. Santander, Nivis Brito, Oriana M. Damas, Amar R. Deshpande et al. · 2020 · Inflammatory Bowel Diseases
50. An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
    Fatima Amanat, Kris M. White, Lisa Miorin, Shirin Strohmeier, Meagan McMahon, Philip S. Meade, Wen‐Chun Liu, Randy A. Albrecht, Viviana R. Simon, Luis Martínez‐Sobrido et al. · 2020 · Current Protocols in Microbiology
51. Changes of hematological and immunological parameters in COVID-19 patients
    Xiaohong Yuan, Wanling Huang, Bing Ye, Cunrong Chen, Rongfeng Huang, Feng Wu, Wei Qin, Wei Zhang, Jianda Hu · 2020 · International Journal of Hematology
52. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
    David Sulzer, Angelo Antonini, Valentina Leta, Anna Starikovsky Nordvig, Richard Jay Smeyne, James E. Goldman, Osama Al‐Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco et al. · 2020 · npj Parkinson s Disease
53. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
    Miquéias Lopes‐Pacheco, Pedro Leme Silva, Fernanda Ferreira Cruz, Denise Battaglini, Chiara Robba, Paolo P. Pelosi, Marcelo Marcos Morales, Celso Caruso Neves, Patrícia R. M. Rocco · 2021 · Frontiers in Physiology
54. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts
    Xiaofeng Zhai, Jiumeng Sun, Ziqing Yan, Jie Zhang, Jin Zhao, Zongzheng Zhao, Qi Gao, Wan-Ting He, Michael Veit, Shuo Su · 2020 · Journal of Virology
55. Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
    Yifan Wang, Caixuan Liu, Chao Zhang, Yanxing Wang, Hong Qin, Shiqi Xu, Zuyang Li, Yong Ping Yang, Zhong Wei Huang, Yao Cong · 2022 · Nature Communications
56. History of the COVID-19 pandemic: Origin, explosion, worldwide spreading
    Sara Platto, Yanqing Wang, Jinfeng Zhou, Ernesto Carafoli · 2020 · Biochemical and Biophysical Research Communications
57. In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
    Ruian Ke, Carolin Zitzmann, David D. Ho, Ruy Miguel Ribeiro, Alan S. Perelson · 2021 · Proceedings of the National Academy of Sciences
58. Profile of a killer: the complex biology powering the coronavirus pandemic
    David Cyranoski · 2020 · Nature
59. Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
    Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed Fahad Alajmi, Afzal Hussain, Md Tabish Rehman, Asimul Islam, Md. Imtaiyaz Hassan · 2020 · Bioscience Reports
60. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples
    Ling Leng, Ruiyuan Cao, Jie Ma, Danlei Mou, Yunping Zhu, Wei Li, Luye Lv, Dunqin Gao, Shikun Zhang, Feng Gong et al. · 2020 · Signal Transduction and Targeted Therapy
61. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
    Fabián Sanchis‐Gomar, Carl J. Lavie, Carme Pérez-Quilis, Brandon Michael Henry, Giuseppe Lippi · 2020 · Mayo Clinic Proceedings
62. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study
    Muhammad Tahir Khan, Arif Ali, Qiankun Wang, Muhammad Irfan, Abbas Khan, Muhammad Tariq Zeb, Yu-Juan Zhang, Sathishkumar Chinnasamy, Dong‐Qing Wei · 2020 · Journal of Biomolecular Structure and Dynamics
63. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan
    Qian Fan, Wei Zhang, Bo Li, Dejia Li, Jian Zhang, Fang Zhao · 2020 · Frontiers in Cellular and Infection Microbiology
64. Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
    Singh, Satarudra Prakash, Pritam, Manisha, Pandey, Brijesh, Yadav, Thakur Prasad · 2021 · Journal of Medical Virology
65. Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment
    Shuntong Kang, Wenyao Peng, Yuhao Zhu, Shi Yao Lu, Min Zhou, Wei Lin, Wenfang Wu, Shu Huang, Liping Jiang, Xuan Luo et al. · 2020 · International Journal of Antimicrobial Agents
66. A multiscale coarse-grained model of the SARS-CoV-2 virion
    Alvin Yu, Alexander J. Pak, Peng He, Viviana Monje‐Galvan, Lorenzo Casalino, Zied Gaieb, Abigail C. Dommer, Rommie E. Amaro, Gregory A. Voth · 2020 · Biophysical Journal
67. mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
    Rauch, Susanne, Roth, Nicole, Schwendt, Kim, Fotin-Mleczek, Mariola, Mueller, Stefan O., Petsch, Benjamin · 2021 · npj Vaccines
68. Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach
    M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Salma Akter, A Rubayet-Ul- Alam, Mohammad Anwar Siddique, Otun Saha, Md. Mizanur Rahaman, Munawar Sultana, Keith A. Crandall et al. · 2020 · PeerJ
69. Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
    Sukrit Narula, Salim Yusuf, Michael Chong, Chinthanie F. Ramasundarahettige, Sumathy Rangarajan, Shrikant I. Bangdiwala, Martin van Eickels, Kirsten Leineweber, Annie Wu, Marie Pigeyre et al. · 2020 · The Lancet
70. Current advances in the development of SARS-CoV-2 vaccines
    Awadasseid, Annoor, Wu, Yanling, Tanaka, Yoshimasa, Zhang, Wen · 2021 · International Journal of Biological Sciences
71. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection
    Valerie B. O’Donnell, David Wayne Thomas, Richard James Stanton, Jean‐Yves Maillard, Robert C. Murphy, Simon A. Jones, Ian Robert Humphreys, Michael J.O. Wakelam, Chris Fegan, Matt P. Wise et al. · 2020 · Function
72. Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures
    Michael M. Laue, Anne Kauter, Tobias Hoffmann, Lars Fodgaard Møller, Janine Michel, Andreas Nitsche · 2021 · Scientific Reports
73. SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
    Andrea Citarella, Angela Scala, Anna Piperno, Nicola Micale · 2021 · Biomolecules
74. Better, Faster, Cheaper: Recent Advances in Cryo–Electron Microscopy
    Eugene Y. D. Chua, Joshua H. Mendez, Micah Rapp, Serban L. Ilca, Yong Zi Tan, Kashyap Maruthi, Huihui Kuang, Christina M. Zimanyi, Anchi Cheng, Edward T. Eng et al. · 2022 · Annual Review of Biochemistry
75. COVID-19 – what should anaethesiologists and intensivists know about it?
    Magdalena Anna Wujtewicz, Anna Dylczyk-Sommer, Aleksander Aszkiełowicz, Szymon Zdanowski, Sebastian Piwowarczyk, Radosław Owczuk · 2020 · Anaesthesiology Intensive Therapy
76. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation
    Matthew McCallum, Alexandra C. Walls, John E. Bowen, Davide Corti, David Veesler · 2020 · Nature Structural & Molecular Biology
77. Arrhythmias and COVID-19
    Parinita Dherange, Joshua P. Lang, Pierre Cheng Qian, Blake Oberfeld, William H. Sauer, Bruce A. Koplan, Usha B. Tedrow · 2020 · JACC. Clinical electrophysiology
78. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
    Madeleine J. Bunders, Marcus A. Altfeld · 2020 · Immunity
79. Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
    Xiaojing Chi, Xiuying Liu, Conghui Wang, Xinhui Zhang, Xiang Li, Jianhua Hou, Lili Ren, Qi Jin, Jianwei Wang, Wei Zhong Yang · 2020 · Nature Communications
80. Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
    Tsun-Yung Kuo, Meei‐Yun Lin, Robert L. Coffman, John D. Campbell, Paula Traquina, Yi-Jiun Lin, Luke Tzu-Chi Liu, Jinyi Cheng, Yu-Chi Wu, Chung-Chin Wu et al. · 2020 · Scientific Reports
81. Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19
    Jhonatas Rodrigues Barbosa, Raul Nunes de Carvalho · 2021 · Trends in Food Science & Technology
82. Cell entry by SARS-CoV-2
    Ruchao Peng, Lian-Ao Wu, Qingling Wang, Jianxun Qi, George F. Gao · 2021 · Trends in Biochemical Sciences
83. Comparison of the immunogenicity of <scp>BNT162b2</scp> and <scp>CoronaVac COVID</scp> ‐19 vaccines in Hong Kong
    Mok, Chris Ka Pun, Cohen, Carolyn A., Cheng, Samuel M. S., Chen, Chunke, Kwok, Kin‐On, Yiu, Karen, Chan, Tat‐On, Bull, Maireid, Ling, Kwun Cheung, Dai, Zixi et al. · 2022 · Respirology
84. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection
    Ana Marija Franceschi, Osama Ashraf Ahmed, Luca Giliberto, Maurício Castillo · 2020 · American Journal of Neuroradiology
85. SARS-CoV-2: characteristics and current advances in research
    Yicheng Yang, Zhiqiang Xiao, Kaiyan Ye, Xiaoen He, Bo Sun, Zhiran Qin, Jianghai Yu, Jinxiu Yao, Qinghua Wu, Zhang Bao et al. · 2020 · Virology Journal
86. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
    Nicholas K. Hurlburt, Emilie Seydoux, Yu-Hsin Wan, Venkata Viswanadh Edara, Andrew B. Stuart, Junli Feng, Mehul S. Suthar, Andrew T. McGuire, Leonidas Stamatatos, Marie Pancera · 2020 · Nature Communications
87. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity
    Junxian Ou, Zhonghua Zhou, Ruixue Dai, Jing Zhang, Shan Zhao, Xiaowei Wu, Wendong Lan, Yi Ren, Lilian Cui, Qiaoshuai Lan et al. · 2021 · Journal of Virology
88. Flavonoids are promising safe therapy against COVID-19
    Moza Mohamed Alzaabi, Rania Hamdy, Naglaa S. Ashmawy, Alshaimaa M. Hamoda, Fatemah Alkhayat, Neda Naser Khademi, Sara Mahmoud Abo Al Joud, Ali El‐Keblawy, Sameh S. M. Soliman · 2021 · Phytochemistry Reviews
89. Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
    Jiansheng Huang, Wenliang Song, Hui Huang, Quancai Sun · 2020 · Journal of Clinical Medicine
90. Does COVID-19 Spread Through Droplets Alone?
    Thushara Galbadage, Brent M. Peterson, Richard S. Gunasekera · 2020 · Frontiers in Public Health
91. Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
    Carleen A. Klumpp-Thomas, Heather R. Kalish, Matthew R. Drew, Sally Hunsberger, Kelly Snead, Michael P. Fay, Jennifer L. Mehalko, Anandakumar Shunmugavel, Vanessa E. Wall, Peter H. Frank et al. · 2021 · Nature Communications
92. Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
    Sebastian Julian Theobald, Alexander Simonis, Theodoros Georgomanolis, Christoph Kreer, Matthias Zehner, Hannah S. Eisfeld, Marie‐Christine Albert, Jason Chhen, Susanne Motameny, Florian Erger et al. · 2021 · EMBO Molecular Medicine
93. Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force microscopy
    Juan Carlos Abrego‐Martinez, Maziar Jafari, Siham Chergui, Catalin Pavel, Diping Che, Mohamed Siaj · 2021 · Biosensors and Bioelectronics
94. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
    M. Joyce, Hannah A. D. King, Ines Elakhal-Naouar, Aslaa Ahmed, Kristina K. Peachman, Camila Macedo Cincotta, C. Subra, Rita E. Chen, P. Thomas, Wei-Hung Chen et al. · 2021 · Science Translational Medicine
95. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
    Ku, Zhiqiang, Xie, Xuping, Davidson, Edgar, Ye, Xiaohua, Su, Hang, Menachery, Vineet D., Li, Yize, Yuan, Zihao, Zhang, Xianwen, Muruato, Antonio E. et al. · 2021 · Nature Communications
96. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19
    Yi Jiang, Wanchao Yin, H. Eric Xu · 2020 · Biochemical and Biophysical Research Communications
97. Advances in the Omicron variant development
    Antonio Vitiello, Francesco Ferrara, Amogh Milind Auti, Marina Di Domenico, Mariarosaria Boccellino · 2022 · Journal of Internal Medicine
98. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
    Tongqing Zhou, Lingshu Wang, John Misasi, Amarendra Pegu, Yi Zhang, Darcy R. Harris, Adam S. Olia, Chloe Adrienna Talana, Eun Sung Yang, Man Chen et al. · 2022 · Science
99. ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
    Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, Matthew McCallum, Dora Pinto, Antonino Cassotta, Mathilde Foglierini, Federico Mele, Rana Abdelnabi, Birgit Weynand et al. · 2022 · Science
100. Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses
     Mahmoud Nasrollahzadeh, Mohaddeseh Sajjadi, Ghazaleh Jamalipour Soufi, Siavash Iravani, Rajender S. Varma · 2020 · Nanomaterials